Just me....I see a need for breakthrough products and big bio's are desperate to increase their shrinking pipelines and replace their products that will be going generic. Big Bio R&D isn't getting it done. It is the little guy, with years of grinding and scrabbling that is getting it done. ATHX is one of those getting it done IMO....
While there are valid points in the article the timing and purpose is suspect. I imagine there will be a more positive article when those behind this one are ready to load.
A lot of bargains again now. Some thoughts from the peanut gallery....GLTA
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM